Nailufar - Sarana Meditama Head Director

All Insiders . Indonesia . 
Stock . Sarana Meditama Metropolitan . Stakeholders . Insider . Nailufar
SAME Stock  IDR 260.00  2.00  0.78%   

Insider

Nailufar is Head Director of Sarana Meditama Metropolitan
Age 59
Phone62 21 2977 9977
Webhttps://www.emc.id

Sarana Meditama Management Efficiency

Sarana Meditama's management efficiency ratios could be used to measure how well Sarana Meditama manages its routine affairs as well as how well it operates its assets and liabilities.
Sarana Meditama Metropolitan has accumulated 20.94 B in total debt with debt to equity ratio (D/E) of 75.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sarana Meditama Metr has a current ratio of 3.79, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Sarana Meditama until it has trouble settling it off, either with new capital or with free cash flow. So, Sarana Meditama's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sarana Meditama Metr sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sarana to invest in growth at high rates of return. When we think about Sarana Meditama's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Lucia IndrayaniAdi Sarana Armada
35
Gunawan PrajitnoSiloam International Hospitals
49
Darjoto BScSiloam International Hospitals
65
Alvin PhangAdi Sarana Armada
50
Marcelino JeharusAdi Sarana Armada
44
MariaSiloam International Hospitals
N/A
Christian SuhermanAdi Sarana Armada
52
Saka NainggolanElang Mahkota Teknologi
N/A
SE MMMitra Keluarga Karyasehat
43
MBA MBAMitra Keluarga Karyasehat
53
SE QIAAdi Sarana Armada
45
Amelia HendraSiloam International Hospitals
N/A
Sri DewiElang Mahkota Teknologi
N/A
Paulus SujonoSiloam International Hospitals
N/A
Ida ZuraidaProdia Widyahusada Tbk
46
Fekly ImmanuelAdi Sarana Armada
45
Magdalena VandryProdia Widyahusada Tbk
N/A
Andya DaniswaraElang Mahkota Teknologi
N/A
Catherine SabatiniSiloam International Hospitals
31
Mochtar RiadySiloam International Hospitals
93
Prodjo SPAdi Sarana Armada
64
PT Sarana Meditama Metropolitan Tbk, together with its subsidiaries, engages in the management of hospitals in Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Omni Health Care. Sarana Meditama is traded on Jakarta Stock Exchange in Indonesia. Sarana Meditama Metropolitan (SAME) is traded on Jakarta Exchange in Indonesia and employs 2,437 people.

Management Performance

Return On Equity-0.0035
Return On Asset0.0015

Sarana Meditama Metr Leadership Team

Elected by the shareholders, the Sarana Meditama's board of directors comprises two types of representatives: Sarana Meditama inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sarana. The board's role is to monitor Sarana Meditama's management team and ensure that shareholders' interests are well served. Sarana Meditama's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sarana Meditama's outside directors are responsible for providing unbiased perspectives on the board's policies.
Armen Djan, CFO Director
Nailufar, Head Director
Agnes Pricilia, Head Audit
Jusup Halimi, CEO Director
Meta MD, Medical Director
Rahmiyati Yahya, Co Sec

Sarana Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sarana Meditama a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.0035
Return On Asset0.0015
Profit Margin(0.01) %
Operating Margin0.01 %
Current Valuation5.14 T
Shares Outstanding17.13 B
Shares Owned By Insiders76.36 %
Shares Owned By Institutions0.09 %
Price To Earning177.12 X
Price To Book1.32 X

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Sarana Stock

Sarana Meditama financial ratios help investors to determine whether Sarana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sarana with respect to the benefits of owning Sarana Meditama security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY